Literature DB >> 4349947

Alterations in cyclic AMP metabolism in human bronchial asthma. 3. Leukocyte and lymphocyte responses to steroids.

C W Parker, M G Huber, M L Baumann.   

Abstract

On the basis of serial studies the responsiveness of leukocytes and lymphocytes from asthmatic donors to catecholamines was increased during high dose corticosteroid therapy. Similar changes were observed in the cells of normal control subjects given 200 mg of hydrocortisone intravenously. The increase in responsiveness did not appear to be due to changes in lymphocyte subpopulations although this may be a contributing factor. In an effort to elucidate the basis for the improved response, in vitro effects of glucocorticoids on lymphocyte cyclic AMP concentrations were investigated. Glucocorticoids (prednisolone succinate, hydrocortisone, hydrocortisone phosphate, and hydrocortisone succinate) stimulated cyclic AMP accumulation in asthma and normal control lymphocytes, increases occurring within the first 2 min of incubation. In the absence of theophylline, responses were regularly obtained at 10 muM hydrocortisone and usually at 1 muM hydrocortisone but not at submicromolar steroid concentrations. Theophylline potentiated the cyclic AMP response to glucocorticoids and also increased the percentage of positive responses in the 0.01-1.0 muM corticosteroid range. Combinations of 1 muM hydrocortisone and 1 muM epinephrine were sometimes additive or synergistic but in many instances higher glucocorticoid concentrations were needed to obtain augmentation of the catecholamine response. The in vitro glucocorticoid effects may not fully explain their potentiating action in vivo.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4349947      PMCID: PMC302397          DOI: 10.1172/JCI107306

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Thymus-derived lymphocytes sequestered in the bone marrow of hydrocortisone-treated mice.

Authors:  J J Cohen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

2.  Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjects.

Authors:  P J Logsdon; E Middleton; R G Coffey
Journal:  J Allergy Clin Immunol       Date:  1972-07       Impact factor: 10.793

3.  Stimulation by growth hormone and dexamethasone of labeled cyclic adenosine 3',5'-monophosphate accumulation by white fat cells.

Authors:  J Moskowitz; J N Fain
Journal:  J Biol Chem       Date:  1970-03-10       Impact factor: 5.157

4.  Adrenal corticosteroid involvement in the control of liver glycogen phosphorylase activity.

Authors:  L D Schaeffer; M Chenoweth; A Dunn
Journal:  Biochim Biophys Acta       Date:  1969-11-18

5.  Corticosteroids and lymphoid cells.

Authors:  H N Claman
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

6.  Assessment and management of severe asthma.

Authors:  A S Rebuck; J Read
Journal:  Am J Med       Date:  1971-12       Impact factor: 4.965

7.  Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation.

Authors:  J W Smith; A L Steiner; W M Newberry; C W Parker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

8.  Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate.

Authors:  A L Steiner; D M Kipnis; R Utiger; C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

9.  Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents.

Authors:  C W Parker; J W Smith
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

10.  Glucocorticoid regulation of ACTH sensitivity of adenyl cyclase in rat fat cell membranes.

Authors:  T Braun; O Hechter
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

View more
  17 in total

1.  Editorial: Management of acute asthma.

Authors: 
Journal:  Br Med J       Date:  1975-10-11

2.  Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol.

Authors:  B J Lipworth; R A Clark; D P Dhillon; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The effect of hydrocortisone on tension and cyclic AMP metabolism in tracheal smooth muscle.

Authors:  R G Andersson; G Kövesi
Journal:  Experientia       Date:  1974-07-15

Review 4.  Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use.

Authors:  A R Tanner; L W Powell
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

5.  Thyroid disease and asthma.

Authors: 
Journal:  Br Med J       Date:  1977-11-05

6.  Endogenous ocular nocardiosis: a clinical and experimental study.

Authors:  J D Bullock
Journal:  Trans Am Ophthalmol Soc       Date:  1983

7.  Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.

Authors:  J A Wald; D E Salazar; H Y Chen; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

8.  Modification by betamethasone of the effects of bronchodilator drugs on cholinergic bronchoconstriction in rats.

Authors:  M J Mattila; R O Salonen
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

9.  Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.

Authors:  E Roilides; K Uhlig; D Venzon; P A Pizzo; T J Walsh
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Regular nebulised terbutaline in chronic obstructive airways disease: dose-response studies fail to detect tolerance.

Authors:  C Teale; S B Pearson
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.